申请人:Hoffmann-La Roche Inc.
公开号:US04526960A1
公开(公告)日:1985-07-02
This invention relates to compounds of the formula ##STR1## wherein R is a hydrogen atom, a lower alkyl, aryl or aryl-(lower alkyl) group, a 5-membered or 6-membered heteroaromatic group in which the hetero atom is nitrogen, oxygen or sulphur or a group of the formula ##STR2## wherein R' is a hydroxy, lower alkoxy, amino, lower alkylamino, di-(lower alkyl)amino or arylamino group, n stands for an integer of 1 to 4, n' stands for an integer of 2 to 10, R.sup.1 and R.sup.2 each are a hydrogen atom or one of R.sup.1 and R.sup.2 is a hydrogen atom and the other is a hydroxy, lower alkoxy or benzyloxy group and X is a group of the formula ##STR3## and pharmaceutically acceptable acid addition salts thereof, a process for their manufacture and medicaments containing them. These compounds and salts possess antitumor activity.
本发明涉及公式为##STR1##的化合物,其中R为氢原子,较低的烷基,芳基或芳基-(较低的烷基)基团,5-成员或6-成员的杂环芳基团,其中杂原子为氮,氧或硫或公式##STR2##中的基团,其中R'为羟基,较低的烷氧基,氨基,较低的烷基氨基,二(较低的烷基)氨基或芳基氨基基团,n代表1到4的整数,n'代表2到10的整数,R1和R2各自为氢原子或其中之一为氢原子,另一个为羟基,较低的烷氧基或苄氧基基团,X为公式##STR3##的基团及其药学上可接受的酸加盐,其制造过程和包含它们的药物。这些化合物和盐具有抗肿瘤活性。